Digital technologies have filtered into nearly every facet of medicine, from drug discovery all the way to consumer fitness. But digital health isn't the only relative newcomer that could disrupt the ...

Precision medicine and genomics are innovations just starting to work their way into the mainstream of healthcare. And electronic health records are beginning to catch up with early use of precision ...

The work of this roundtable engages a variety of interested parties to encourage innovation, spur adoption and implementation, and shape dialogue in genomics and precision health. Roundtable ...

Salt Lake City-based Intermountain Healthcare plans to offer hereditary cancer gene panels through the Intermountain Precision Genomics Core Laboratory in St. George, Utah, the health system announced ...

As a result of genomics being a big part of medical research in recent decades, numerous tests have passed the clinical evidence threshold into standard of care (SOC) and are reimbursed as medically ...

Intermountain Precision Genomics will add 10x Genomics’ Chromium Genome Solution to Intermountain’s Translational Science Center. The center already houses several of the latest high-throughput, ...

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...

Six months into his role as executive director of Intermountain Precision Genomics, the gravity of the task set in for Dr. Lincoln Nadauld. Nadauld was brought in to lead Precision Genomics, the ...

The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market ...

Intermountain Healthcare is a Utah-based not-for-profit system of 23 hospitals and 170 clinics that employs close to 2300 physicians and advanced practice clinicians. It serves patients through its ...

New research presented at the 2021 American Society of Clinical Oncology Annual Meeting is painting a clearer picture of what drives differences in mortality and outcomes for patients with prostate ...